Jolife AB announces launch of LUCAS™2, the new generation of LUCAS Chest Compression System, in Europe and Canada
Lund, Sweden, 22nd of June 2009
Now electrically powered, the life-saving medical device offers the most lightweight and compact solution to maintain circulation in cardiac arrest patients.
Jolife AB announces the launch of its second generation LUCAS™ Chest Compression System - intended for use in cardiopulmonary resuscitation (CPR) of cardiac arrest patients - in Europe and Canada. LUCAS mechanical chest compressions help keep the personnel safe and have shown to increase operational efficacy of emergency care systems as well as the opportunities for improved patient outcomes.
The second generation LUCAS™2 builds upon the well-proven LUCAS™1 technology, but with a change of driving source from pneumatic to electric. LUCAS™2 may be operated either on battery alone or from the wall or car electricity outlets. This increases operational flexibility as well as reliability whether the patient is treated by ambulance personnel in the field or in the hospital. It is now one unit to carry and store, and incorporates new features such as alerts and pauses to aid ventilation during compressions, a softer start at adjustment to the patient’s chest and a quieter operation.
“With the LUCAS™2 we now offer a solution to customers that prefer a battery powered device, and the LUCAS™1 for those who prefer the pneumatic solution”, says Erik von Schenck, CEO of JOLIFE AB. “The modern battery requires a minimum of maintenance, and makes the device the most compact, lightweight and portable mechanical CPR device on the market”.
LUCAS™2 is CE-marked for sales in Europe and has got approval also in Canada and will be commercially available after the summer. LUCAS™2 is developed and manufactured by Jolife AB, Lund, Sweden, and distributed worldwide by Physio-Control, Inc., a division of Medtronic Inc.
About LUCAS CPR
LUCAS Chest Compression System is an easy-to-use and lightweight device that provides quality chest compressions according to the European Resuscitation Council and American Heart Association Guidelines for CPR (cardiopulmonary resuscitation). It assists rescuers in maintaining vital blood circulation in cardiac arrest patients. LUCAS is simple to use, applied within seconds and feasible for use in a majority of cardiac arrest patients. The mechanical CPR device has been shown to increase blood circulation to the heart and brain, and to be as safe as manual compressions.
About Jolife AB
Jolife AB, founded in 2000, develops and manufactures the LUCAS Chest Compression System. Jolife works closely with leading physicians and paramedics and is committed to research and development in order to continue to offer innovative products. The LUCAS Chest Compression Systems are sold in the major markets in the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Inc. – except in Sweden, Norway and Finland, where Jolife sells direct.